Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA243041
Max Phase: Preclinical
Molecular Formula: C21H19N3OS
Molecular Weight: 361.47
Molecule Type: Small molecule
Associated Items:
ID: ALA243041
Max Phase: Preclinical
Molecular Formula: C21H19N3OS
Molecular Weight: 361.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=S)Nc1ccc(OCCn2c3ccccc3c3ccccc32)cc1
Standard InChI: InChI=1S/C21H19N3OS/c22-21(26)23-15-9-11-16(12-10-15)25-14-13-24-19-7-3-1-5-17(19)18-6-2-4-8-20(18)24/h1-12H,13-14H2,(H3,22,23,26)
Standard InChI Key: NXZWOHQDWDBTTO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 361.47 | Molecular Weight (Monoisotopic): 361.1249 | AlogP: 4.53 | #Rotatable Bonds: 5 |
Polar Surface Area: 52.21 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.89 | CX Basic pKa: | CX LogP: 4.75 | CX LogD: 4.75 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.51 | Np Likeness Score: -1.22 |
1. Kim YJ, Ryu JH, Cheon YJ, Lim HJ, Jeon R.. (2007) Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production., 17 (12): [PMID:17467989] [10.1016/j.bmcl.2007.04.005] |
Source(1):